Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion
Published inRheumatology, vol. 50, no. 1, p. 243-244
Publication date2011
Keywords
- Aged
- Antirheumatic Agents/adverse effects
- Arthritis, Rheumatoid/drug therapy
- B-Lymphocytes/drug effects
- Biological Agents/adverse effects
- Female
- Humans
- Immunoconjugates/adverse effects
- Male
- Middle Aged
- Switzerland
Affiliation
Citation (ISO format)
WALKER, Ulrich A et al. Do new biologics meet the unmet medical need in rheumatoid arthritis? Safety and efficacy of abatacept following B-cell depletion. In: Rheumatology, 2011, vol. 50, n° 1, p. 243–244. doi: 10.1093/rheumatology/keq258
Main files (1)
Article (Published version)
Identifiers
- PID : unige:25087
- DOI : 10.1093/rheumatology/keq258
- PMID : 20716674
ISSN of the journal1462-0324
